Basiliximab Treating Interstitial Pneumonia of CADM
NCT03192657
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Lung; Disease, Interstitial, With Fibrosis
Dermatomyositis
Interventions
DRUG:
Basiliximab
DRUG:
Calcineurin Inhibitors
DRUG:
Steroids
Sponsor
RenJi Hospital